Effect of dimethyl fumarate standard versus 4 week up-titration (slow) on gastrointestinal tolerability in subject with relapsing-remitting multiple sclerosis (RRMS).
Phase of Trial: Phase III
Latest Information Update: 25 Feb 2016
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 25 Feb 2016 New trial record